Alpha 2.0
Login Register
» Articles » PMID: 37131864

Could Beta Variant Containing COVID-19 Booster Vaccines Tackle Omicron Variants?

Overview
Journal Lancet Reg Health Eur
Specialty Health Services
Date 2023 May 3
PMID 37131864
Authors
Pengfei Jin
Fengcai Zhu
Affiliations
Soon will be listed here.
Citing Articles

The role of cross-reactive immunity to emerging coronaviruses: Implications for novel universal mucosal vaccine design.

Alturaiki W Saudi Med J. 2023; 44(10):965-972.

PMID: 37777266 PMC: 10541972. DOI: 10.15537/smj.2023.44.10.20230375.

References
1.
Callaway E . The next generation of coronavirus vaccines: a graphical guide. Nature. 2023; 614(7946):22-25. DOI: 10.1038/d41586-023-00220-z. View
2.
Link-Gelles R, Ciesla A, Roper L, Scobie H, Ali A, Miller J . Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to.... MMWR Morb Mortal Wkly Rep. 2023; 72(5):119-124. PMC: 9927070. DOI: 10.15585/mmwr.mm7205e1. View
3.
Corominas J, Garriga C, Prenafeta A, Moros A, Canete M, Barreiro A . Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial. Lancet Reg Health Eur. 2023; 28:100613. PMC: 10102678. DOI: 10.1016/j.lanepe.2023.100613. View
4.
Chalkias S, Harper C, Vrbicky K, Walsh S, Essink B, Brosz A . A Bivalent Omicron-Containing Booster Vaccine against Covid-19. N Engl J Med. 2022; 387(14):1279-1291. PMC: 9511634. DOI: 10.1056/NEJMoa2208343. View
5.
Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y . Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2022; 186(2):279-286.e8. PMC: 9747694. DOI: 10.1016/j.cell.2022.12.018. View